Revolutionizing Diabetes Treatment: Alpha Cells as Natural GLP-1 Producers

New research reveals pancreatic alpha cells can naturally produce GLP-1, a hormone that boosts insulin and may transform type 2 diabetes treatment by leveraging the body's own hormone production mechanisms.
Recent research from Duke University School of Medicine has challenged traditional views on blood sugar regulation by revealing an unexpected function of pancreatic alpha cells. Previously thought to only produce glucagon—a hormone involved in raising blood sugar during fasting or exercise—these cells are now found to also generate GLP-1, a potent hormone that enhances insulin release and helps regulate glucose levels. Using advanced mass spectrometry techniques, scientists discovered that human alpha cells naturally produce higher levels of bioactive GLP-1 than previously recognized, and this production is directly linked to insulin secretion.
Led by Dr. Jonathan Campbell, the research team examined pancreatic tissues from humans and mice across various ages, weights, and diabetic conditions. Their findings suggest that alpha cells are more adaptable, capable of adjusting hormone output to support beta cells and maintain blood sugar homeostasis. Notably, when glucagon production was blocked in mouse models, alpha cells increased GLP-1 produção, which improved glucose control and stimulated greater insulin release—indicating that GLP-1 can compensate when glucagon synthesis is inhibited.
This discovery has significant implications for diabetes treatment. Although GLP-1 is mainly produced in the gut, this study confirms pancreatic alpha cells can also secrete this hormone into the bloodstream after eating, contributing to blood sugar regulation. Mild metabolic challenges, such as high-fat diets, can modestly boost GLP-1 production from alpha cells, opening new avenues for therapies that aim to enhance the body's natural hormone production. The research team developed a precise mass spectrometry assay to measure bioactive GLP-1 accurately, which may facilitate future studies on boosting GLP-1 levels.
Dr. Campbell emphasizes that these findings suggest the body has a built-in contingency plan: in times of metabolic stress, alpha cells switch from producing glucagon to generating GLP-1, providing a natural mechanism to support insulin secretion and maintain glucose balance. This hormone shift could pave the way for innovative diabetes treatments that harness the body's own cells to produce GLP-1, potentially offering more natural and effective management of blood sugar levels.
Source: https://medicalxpress.com/news/2025-09-alpha-cells-moonlight-secret-glp.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Experts Warn of a Complex Vaccine Landscape in 2025
Experts warn that vaccine accessibility and policy changes in 2025 could complicate COVID-19 and flu prevention efforts, impacting vulnerable populations the most.
WHO Supports Access to Affordable Weight-Loss Medications and Promotes Generic Alternatives
WHO recommends key weight-loss medications for global use and urges the production of affordable generic versions to improve access in developing countries, aiming to combat obesity and related health issues worldwide.
Neural Maps of Rewards May Be Impaired in Dementia and Amplified in Addiction
New research reveals how brain's reward maps function in dementia and addiction, offering insights into potential therapies for memory and behavioral disorders.



